Budget Express 2026

co-presented by

ASSOCIATE SPONSORS

HomeNewsMorphine sulphate er tablets

Morphine Sulphate Er Tablets

Jump to

Cadila Health up 3%, Zydus to market pain killer drug in US

"The Zydus group has received the market authorisation from the US Food and Drug Administration (USFDA) to market Morphine sulphate ER tablets," said the company in its filing to the exchange.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347